Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Folican Gold is an oral nutritional supplement developed and marketed by Med Manor Organics. Formulated as a softgel capsule, it is a fixed-dose combination of five active ingredients: levomefolic acid (L-methylfolate), methylcobalamin (vitamin B12), pyridoxal-5-phosphate (vitamin B6), cholecalciferol (vitamin D3), and docosahexaenoic acid (DHA). Folican Gold is primarily indicated for the prevention and treatment of nutritional deficiencies, particularly during preconception, pregnancy, and lactation. It supports maternal health, prevents neural tube defects, aids in red blood cell formation, and promotes fetal brain and neurological development.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Folican Gold.